iPSC-based cell therapy is a valuable tool for treating both malignant and non-malignant human diseases. So far, many attempts have been made to harness iPSC-derived NK cells with the purpose to provide cell therapies for patients suffered from different cancers. Currently, Creative Biolabs offers a series of custom iPSC-derived NK cell services to help our clients generate NK cells from iPSCs for future cell therapy applications. Learn more, https://www.creative-biola...

Only people mentioned by cailynn in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from cailynn johnson, click on at the bottom under it